CSA Medical completes enrolment in chronic bronchitis trial
CSA Medical has completed enrolment in its SPRAY-CB trial (NCT03893370) for patients with chronic obstructive pulmonary disease (COPD) with chronic…
Latest News
-
-
How will a Labour government support the UK clinical trials industry?
On 4 July 2024, the people of the UK took to the polls and made their voice heard, voting for…
-
AI database to bolster research for GLP1-RAs as precision medicines
An AI database that utilises real-world data (RWD) could help sponsors decide where to next investigate glucagon-like peptide-1 receptor agonists…
-
Further positive results reported from Sebela’s investigational IUD
Sebela Women's Health has announced it has further positive results in a pivotal Phase III open-label study of the investigational…
-
AstraZeneca hopes to make clinical trial operations carbon-negative by 2030
AstraZeneca has big plans to become carbon-negative by 2030, including collecting human samples obtained in clinical trials. The company is…
-
Push for more NHS organisations to get involved in clinical research
There is hope that everyone in the UK's National Health Service (NHS) to get involved in clinical research, said professor…
-
Headband to treat mild and moderate Alzheimer’s disease to be trialled
Electro Cellular Healthcare Solutions (ECHS) is trialling a wearable headband device to treat patients with mild to moderate Alzheimer’s disease…
-
SeaStar resolves supply chain issue to initiate trial enrolment
Seastar Medical Holding Corporation has resolved supply chain concerns that impacted the sourcing of a component (tubing connectors) for the…
-
Relievant’s procedure provides long-term relief for chronic back pain
Relievant Medsystems has published a study detailing three-year pooled results from clinical trials evaluating the Intracept procedure for patients with…
-
Cellf Bio’s first-in-human implantation of BioSphincter
Cellf Bio has reported the first human implantation of its autologous bioengineered sphincter BioSphincter in a Phase I clinical trial…
